|
⚲
|
| Keyboard |
| Cain Christopher W
✚
|
|
|---|---|
| CIK # | 0001817733 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001817733] | |
| 4 | [0001817733] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Miragen Therapeutics Inc | |
| Cain Christopher W | |
| Jade Biosciences Inc | |
| Cogent Biosciences Inc | |
| Damora Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-07-01 | Grant | 21,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 44,700 | $0.00 | |
|
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 23,017 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-03-10 | Grant | 42,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 44,700 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2023-06-07 | Grant | 36,700 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2022-06-07 | Grant | 30,700 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2021-03-11 | Grant | 60,000 | $0.00 | |
|
Cogent Biosciences Inc UMRX
Director Stock Option (Right to Buy) · derivative
|
2020-08-27 | Grant | 28,661 | $0.00 |